Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy

Authors

  • Pasquale Niscola Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Nélida Inés Noguera Neuro Oncohematology Unit, Santa Lucia Foundation and Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy
  • Gianfranco Catalano Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Luca Cupelli Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Stefano Fratoni Department of Pathology, Saint’ Eugenio Hospital, Rome, Italy
  • Marco Giovannini Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Carla Mazzone Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Benedetta Neri Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Laura Scaramucci Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Malgorzata Monika Trawinska Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Paolo de Fabritiis Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy
  • Elisabetta Abruzzese Hematology Unit, Saint’ Eugenio Hospital, Tor Vergata University of Rome, Rome, Italy

DOI:

https://doi.org/10.1080/0284186X.2019.1585943

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2019-06-03

How to Cite

Niscola, P. ., Inés Noguera, N. ., Catalano, G., Cupelli, L. ., Fratoni, S. ., Giovannini, M. ., … Abruzzese, E. . (2019). Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy. Acta Oncologica, 58(6), 888–890. https://doi.org/10.1080/0284186X.2019.1585943